All News

PSORIASIS.LH_.jpg

Psoriatic Disease Management - RNL 2021 Highlights

d Robert Chao, MD

This year’s coverage of psoriatic arthritis was once again, both exciting and informative. Topics included an overview of the latest therapeutic options, an excellent discussion on psoriasis specifically, and the epidemiology of psoriatic arthritis. 

Read Article
vasculitis.Churg-Strauss_syndrome.wikipedia.jpg

Serious Infections Still Common in Vasculitis

d MedPage Today

Serious infections occurred more frequently among patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis who were given induction therapy with cyclophosphamide compared with rituximab (Rituxan), Greek researchers found.

Read Article
RheumNow Podcast square

RheumNow Podcast – Infection in ANCA-Associated Vasculitis (3.26.2021)

d Jack Cush, MD

Dr. Jack Cush reviews the news, FDA Denials and journal articles from the past week on RheumNow.com.

Read Article
Congratulations to the NIH's John J. O’Shea, M.D., who has been awarded NIAMS Harrington Prize for Innovation in Medicine. Dr. O’Shea is a scientific director at NIAMS and receives the Harrington Prize for his work on the rold of Janus Kinase https://t.co/lUbWKMrdiU

Links:

Dr. John Cush RheumNow ( View Tweet)

A prevention trial shows atorvastatin failed to prevent RA onset - 62 pts with preclinical RA (arthralgia, +CCP/RF) randomized to PBO or statin. After 14 mos, arthritis developed in 29% with atorvastatin and 19% with placebo. https://t.co/HikuDkwNu7 https://t.co/QyGy81lgcq

Links:

Dr. John Cush RheumNow ( View Tweet)
“Give as much glucocorticoids as necessary but as little as possible!” – Dr. F Buttgereit #RNL2021 #RheumNow Original tweet from Dr. Kathryn Dao @KDAO2011

Dr. John Cush RheumNow ( View Tweet)

Takeaways from #RNL2021 from Dr. Rachel Tate ( @uptoTate ) "Severe flares in PsO pts previously well controlled: look for infection (HIV or other) and/or underlying malignancy. Melodie Young, NP #RNL2021" #RheumNow

Dr. John Cush RheumNow ( View Tweet)

Listen to our latest QD clinic--Why Pain Consults present Not Taking Pain Meds https://t.co/75YO027Oh6 https://t.co/QrbiBnGbGd

Links:

Dr. John Cush RheumNow ( View Tweet)
The Reflecting Rheum: 2020 SpA and Still’s Disease Highlights Sponsored by Novartis Medical Affairs Listen to a discussion of medical experts share their views on the most impactful work done in spondyloarthritis and Still’s disease in 2020. https://t.co/Kp2drDAqFv https://t.co/6oOGSq0Psl

Links:

Dr. John Cush RheumNow ( View Tweet)
QD147 Pain, but No Pain Meds QD Clinic - Lessons from the clinic Why Pain Consults present Not Taking Pain Meds Features Dr. Jack Cush https://t.co/yRNh6QraED

Links:

Dr. John Cush RheumNow ( View Tweet)

Potent Topical Corticosteroids and the Risk of Osteoporotic Fractures https://t.co/OHohMKveik

Links:

Dr. John Cush RheumNow ( View Tweet)

#RNL2021 Thanks @uptoTate https://t.co/VKFodPOwgC

Links:

Dr. John Cush RheumNow ( View Tweet)

#RNL2021 coverage by @uptoTate for #RheumNow https://t.co/x1GjGGNPii

Links:

Dr. John Cush RheumNow ( View Tweet)

Great #RNL2021 coverage by @KDAO2011 for #RheumNow https://t.co/GBnlyvPaz1

Links:

Dr. John Cush RheumNow ( View Tweet)

Liver Management in RA - #RNL2021 Highlight by @DrPetryna While RA is not known to affect the liver directly, underlying liver disease and treatment-related effects on the liver can often become an obstacle in the mgmt of many RA patients. https://t.co/OeuloDIXMF

Links:

Dr. John Cush RheumNow ( View Tweet)

New RheumNow Podcast Now Available! Infection in ANCA-Associated Vasculitis https://t.co/Twy04G9RU1 Download wherever podcasts are available!

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast – Infection in ANCA-Associated Vasculitis Dr. Jack Cush reviews the news, FDA Denials and journal articles from the past week on https://t.co/4GKxMY5Lll https://t.co/joi1puBSuX

Links:

Dr. John Cush RheumNow ( View Tweet)

#RNL2021 coverage from @KDAO2011 #RheumNow https://t.co/GBnlyvPaz1

Links:

Dr. John Cush RheumNow ( View Tweet)

Are You a Super Rheum? https://t.co/omvQXwhcoV https://t.co/8iQaRAi5di

Links:

Dr. John Cush RheumNow ( View Tweet)
Analysis of CPRD registry and 15670 MTX treated pts (46,571 PYs) showed discontinuation for abnormal or severely abnormal labs was 42/1000PY and 6/1,000PY; half that after Yr 1 (22 & 2.84). D/C for severe labs was 1 in 169 Yr1 & 1 in 352 per year after https://t.co/Dx91YqjplT

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×